05.30.23 -- FDA's Digital Health Tech Framework Addresses Challenges

Learn about a next-generation cryoprotectant agent carving a new path to accelerate optimal treatments for patients in the overall field of biologics.

Although polymer bags are an excellent choice for cold chain use, not all polymer films perform the same way, even if their specifications rate them for use at low temperatures.

Explore five key benefits of genderless aseptic connectors and how they can lead to more flexibility, reduced risk, and lower costs for your organization.

The dynamic nature of inherently complex cell therapy-focused clinical trials requires individuals with a keen understanding of site and partner needs communicating effectively.

While the first autologous cell therapy commercial products have shown tremendous clinical success, scaling out these therapies while considering individual patient processes is a new challenge.

Discover how in silico trials meet ethical codes and can be used to evaluate drug candidates.

Real-world evidence (RWE) can contribute valuable information to new medicine registrations, particularly for diseases that are difficult to assess in randomized clinical trials (RCTs) and for emerging technologies.

Discover how a clinical-stage biotechnology company was able to successfully file its IND submissions and complete CSR publishing tasks, in addition to creating a synchronized team capable of accommodating ad hoc publishing requests.

Explore the Quantum Flex Cell Expansion System as a robust environment to advance your T cell cultures from preclinical development to commercialization.